Diagnostic value of transferrin

Clinica Chimica Acta

Volumn 413, Issue 15-16, 2012, Pages 1184-1189

  Szoke, Dominika ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Iron deficiency; Iron overload; Risk marker; Transferrin

Indexed keywords

CD71 ANTIGEN; ERYTHROPOIETIN; FERRITIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR 2;

CANCER RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ERYTHROPOIESIS; GENE; GENE MUTATION; GENETIC SCREENING; HEMATOLOGICAL PARAMETERS; HEMOCHROMATOSIS; HFE GENE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON ABSORPTION; IRON BALANCE; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON STORAGE; IRON THERAPY; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRANSFERRIN BLOOD LEVEL; TRANSFERRIN SATURATION;

ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; DEFICIENCY DISEASES; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; META-ANALYSIS AS TOPIC; PREDICTIVE VALUE OF TESTS; TRANSFERRIN;

EID: 84861330629     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.04.021     Document Type: Review

References (53)

1. Muñoz M., Villar I., García-Erce J.A. An update on iron physiology. World J Gastroenterol 2009, 15:4617-4626.
2. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008, 88:7-15.
3. Franchini M., Montagnana M., Lippi G. Hepcidin and iron metabolism: from laboratory to clinical implications. Clin Chim Acta 2010, 411:1565-1569.
4. Moyer T.P., Highsmith W.E., Smyrk T.C., Gross J.B. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta 2011, 412:1485-1492.
5. Kemna E.H., Tjalsma H., Willems H.L., Swinkels D.W. Hepcidin: from discovery to differential diagnosis. Haematologica 2008, 93:90-97.
6. Singh B., Arora S., Agrawal P., Gupta S.K. Hepcidin: a novel peptide hormone regulating iron metabolism. Clin Chim Acta 2011, 412:823-830.
7. Finberg K.E. Unraveling mechanisms regulating systemic iron homeostasis. Hematology Am Soc Hematol Educ Program 2011, 2011:532-537.
8. Siah C.W., Ombiga J., Adams L.A., Trinder D., Olynyk J.K. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006, 27:5-16.
9. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011, 434:365-381.
10. MacKenzie E.L., Iwasaki K., Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008, 10:997-1030.
11. Baker H.M., Anderson B.F., Baker E.N. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci U S A 2003, 100:3579-3583.
12. World Health Organization Centers for disease control and prevention. Assessing the iron status of populations 2007, including Literature Reviews. Second edition.
13. Wood J.C. Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol 2007, 82:1132-1135.
14. Zimmermann M.B. Methods to assess iron and iodine status. Br J Nutr 2008, 99(Suppl. 3):S2-S9.
15. Beutler E., Hoffbrand A.V., Cook J.D. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program 2003, 40-61.
16. Higgins T., Eckfeldt J.H., Barton J.C., Doumas B.T. Hemoglobin, iron, and bilirubin. Tietz textbook of clinical chemistry and molecular diagnostics 2012, 985-1030. Elsevier Saunders, St. Louis. 5th ed. C.A. Burtis, E.R. Ashwood, D.E. Bruns (Eds.).
17. Hawkins R.C. Total iron binding capacity or transferrin concentration alone outperforms iron and saturation indices in predicting iron deficiency. Clin Chim Acta 2007, 380:203-207.
18. Miller W.G., Myers G.L., Ashwood E.R., et al. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med 2008, 132:838-846.
19. Goddard A.F., James M.W., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anaemia. Gut 2011, 60:1309-1316. on behalf of the British Society of Gastroenterology.
20. Cook J.D. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005, 18:319-332.
21. Muñoz M., García-Erce J.A., Remacha Á.F. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 2011, 64:287-296.
22. Guyatt G.H., Oxman A.D., Ali M., Willan A., McIlroy W., Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992, 7:145-153.
23. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
24. Mei Z., Cogswell M.E., Parvanta I., et al. Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 2005, 135:1974-1980.
25. Guidelines & protocols. Iron deficiency - investigation and management British Columbia Medical Association Advisory Committee, Available at:, Last access: 28.February.2012. http://www.bcguidelines.ca/guideline_iron_deficiency.html.
26. Wish J.B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006, (Suppl. 1):S4-S8.
27. Agency for Healthcare Research, Quality Evidence-based practice center systematic review protocol: laboratory biomarkers for iron deficiency anemia in late stage chronic kidney disease Available at, Last access: 28.February.2012. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=767&pageaction=displayproduct.
28. White C.T., Barrett B.J., Madore F., et al. Clinical practice guidelines for evaluation of anemia. Kidney Int 2008, 74:S4-S6.
29. Madore F., White C.T., Foley R.N., et al. Clinical practice guidelines for assessment and management of iron deficiency. Kidney Int 2008, 74:S7-S11.
30. National Kidney Foundation KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006, 47(Suppl. 3):S1-S145.
31. NCGC National Clinical Guideline Centre Anaemia management in chronic kidney disease. Rapid update 2011 2011, Royal College of Physicians, London, UK.
32. Besarab A., Amin N., Ahsan M., et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000, 11:530-538.
33. Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005, 352:1769-1778.
34. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996, 13:399-408.
35. Fleming R.E., Britton R.S., Waheed A., Sly W.S., Bacon B.R. Pathophysiology of hereditary hemochromatosis. Semin Liver Dis 2005, 25:411-419.
36. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004, 350:2383-2397.
37. Fleming R.E., Ponka P. Iron overload in human disease. N Engl J Med 2012, 366:348-359.
38. Goswami T., Andrews N.C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006, 281:28494-28498.
39. Koziol J.A., Ho N.J., Felitti V.J., Beutler E. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 2001, 47:1804-1810.
40. Adams P., Brissot P., Powell L.W. EASL international consensus conference on haemochromatosis. J Hepatol 2000, 33:485-504.
41. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002, 359:211-218.
42. European Association for the Study of the Liver EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010, 53:3-22.
43. Swinkels D.W., Jorna A.T., Raymakers R.A. Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis. Neth J Med 2007, 65:452-455.
44. Thorstensen K., Kvitland M.A., Irgens W.O., Hveem K., Asberg A. Screening for C282Y homozygosity in a Norwegian population (HUNT2): the sensitivity and specificity of transferrin saturation. Scand J Clin Lab Invest 2010, 70:92-97.
45. Jackson H.A., Carter K., Darke C., et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001, 114:474-484.
46. Bacon B.R., Adams P.C., Kowdley K.V., Powell L.W., Tavill A.S. American association for the study of liver diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011, 54:328-343.
47. Danesh J., Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999, 99:852-854.
48. Ellervik C., Mandrup-Poulsen T., Andersen H.U., et al. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care 2011, 34:2256-2258.
49. Ellervik C., Tybjaerg-Hansen A., Nordestgaard B.G. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis. J Intern Med 2012, 271:51-63.
50. Ellervik C., Tybjærg-Hansen A., Nordestgaard B.G. Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. Clin Chem 2011, 57:459-466.
51. Niederau C., Fischer R., Pürschel A., Stremmel W., Häussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996, 110:1107-1119.
52. Qaseem A., Aronson M., Fitterman N., Snow V., Weiss K.B., Owens D.K. Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2005, 143:517-521.
53. Schmitt B., Bolub M., Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 2005, 143:522-536.